Home > News > Nanogen Shares Nosedive as Q2 Loss Nearly Doubles
August 4th, 2004
Nanogen Shares Nosedive as Q2 Loss Nearly Doubles
Nanogen Inc., maker of the NanoChip molecular diagnostics system for biologic research, saw its stock drop nearly 21 percent today after posting a second-quarter loss that almost doubled its loss of a year ago. Nanogen shares (Nasdaq: NGEN) fell 99 cents, or 20.6 percent, to close at $3.81 today. The firm has a market cap of $97.65 million.
Aspen Aerogels, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 October 17th, 2014
Nanometrics to Announce Third Quarter Financial Results on October 28, 2014 October 8th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520 August 12th, 2014